documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
39 rows where docket_id = "FDA-2020-D-1137" and posted_year = 2020 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-D-1137-0060 | FDA | None FDA-2020-D-1137 | Guidance Documents Related to Coronavirus Disease 2019; Availability | Notice | Notice of Availability | 2020-11-18T05:00:00Z | 2020 | 11 | 2020-11-18T05:00:00Z | 2021-04-03T01:00:48Z | 2020-25399 | 0 | 0 | 0900006484966237 | |
| FDA-2020-D-1137-0049 | FDA | None FDA-2020-D-1137 | Reference 15 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:08:24Z | 0 | 0 | 0900006484946de1 | |||
| FDA-2020-D-1137-0053 | FDA | None FDA-2020-D-1137 | Reference 19 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:08:58Z | 0 | 0 | 0900006484946de9 | |||
| FDA-2020-D-1137-0041 | FDA | None FDA-2020-D-1137 | Reference 6 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:07:23Z | 0 | 0 | 0900006484946dd9 | |||
| FDA-2020-D-1137-0038 | FDA | None FDA-2020-D-1137 | Reference 2 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:07:00Z | 0 | 0 | 09000064849467af | |||
| FDA-2020-D-1137-0043 | FDA | None FDA-2020-D-1137 | Reference 8 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:07:38Z | 0 | 0 | 0900006484946ddb | |||
| FDA-2020-D-1137-0044 | FDA | None FDA-2020-D-1137 | Reference 9 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:07:45Z | 0 | 0 | 0900006484946ddc | |||
| FDA-2020-D-1137-0052 | FDA | None FDA-2020-D-1137 | Reference 18 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:08:51Z | 0 | 0 | 0900006484946de8 | |||
| FDA-2020-D-1137-0047 | FDA | None FDA-2020-D-1137 | Reference 13 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:08:09Z | 0 | 0 | 0900006484946ddf | |||
| FDA-2020-D-1137-0057 | FDA | None FDA-2020-D-1137 | Reference 23 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:09:30Z | 0 | 0 | 0900006484946ded | |||
| FDA-2020-D-1137-0040 | FDA | None FDA-2020-D-1137 | Reference 4 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:07:16Z | 0 | 0 | 0900006484946dd8 | |||
| FDA-2020-D-1137-0048 | FDA | None FDA-2020-D-1137 | Reference 14 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:08:16Z | 0 | 0 | 0900006484946de0 | |||
| FDA-2020-D-1137-0039 | FDA | None FDA-2020-D-1137 | Reference 3 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:07:07Z | 0 | 0 | 09000064849467b0 | |||
| FDA-2020-D-1137-0050 | FDA | None FDA-2020-D-1137 | Reference 16 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:08:31Z | 0 | 0 | 0900006484946de6 | |||
| FDA-2020-D-1137-0046 | FDA | None FDA-2020-D-1137 | Reference 12 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:08:00Z | 0 | 0 | 0900006484946dde | |||
| FDA-2020-D-1137-0055 | FDA | None FDA-2020-D-1137 | Reference 21 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:09:15Z | 0 | 0 | 0900006484946deb | |||
| FDA-2020-D-1137-0037 | FDA | None FDA-2020-D-1137 | Reference 1 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:06:53Z | 0 | 0 | 09000064849467ae | |||
| FDA-2020-D-1137-0051 | FDA | None FDA-2020-D-1137 | Reference 17 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:08:38Z | 0 | 0 | 0900006484946de7 | |||
| FDA-2020-D-1137-0042 | FDA | None FDA-2020-D-1137 | Reference 7 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:07:29Z | 0 | 0 | 0900006484946dda | |||
| FDA-2020-D-1137-0056 | FDA | None FDA-2020-D-1137 | Reference 22 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:09:23Z | 0 | 0 | 0900006484946dec | |||
| FDA-2020-D-1137-0045 | FDA | None FDA-2020-D-1137 | Reference 10 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:07:53Z | 0 | 0 | 0900006484946ddd | |||
| FDA-2020-D-1137-0054 | FDA | None FDA-2020-D-1137 | Reference 20 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Supporting & Related Material | Background Material | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T20:09:05Z | 0 | 0 | 0900006484946dea | |||
| FDA-2020-D-1137-0036 | FDA | None FDA-2020-D-1137 | Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry | Other | Guidance | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T05:00:00Z | 2023-10-20T20:52:16Z | 0 | 0 | 0900006484946dee | ||
| FDA-2020-D-1137-0033 | FDA | None FDA-2020-D-1137 | Ref 7 - Arabi re Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Supporting & Related Material | Background Material | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T16:27:18Z | 0 | 0 | 090000648486b9c9 | |||
| FDA-2020-D-1137-0028 | FDA | None FDA-2020-D-1137 | Ref 4 - Duan re Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Supporting & Related Material | Background Material | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T16:27:15Z | 0 | 0 | 090000648486b873 | |||
| FDA-2020-D-1137-0034 | FDA | None FDA-2020-D-1137 | Ref 6 - Leider re Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Supporting & Related Material | Background Material | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T16:27:19Z | 0 | 0 | 090000648486b9c8 | |||
| FDA-2020-D-1137-0029 | FDA | None FDA-2020-D-1137 | Ref 3 - Chen re Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Supporting & Related Material | Background Material | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T16:27:16Z | 0 | 0 | 090000648486b872 | |||
| FDA-2020-D-1137-0035 | FDA | None FDA-2020-D-1137 | Ref 5 - Cheng re Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Supporting & Related Material | Background Material | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T16:27:19Z | 0 | 0 | 090000648486b9c7 | |||
| FDA-2020-D-1137-0031 | FDA | None FDA-2020-D-1137 | Ref 1 - Roback re Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Supporting & Related Material | Background Material | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T16:27:17Z | 0 | 0 | 090000648486b870 | |||
| FDA-2020-D-1137-0030 | FDA | None FDA-2020-D-1137 | Ref 2 - Shen re Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Supporting & Related Material | Background Material | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T16:27:16Z | 0 | 0 | 090000648486b871 | |||
| FDA-2020-D-1137-0032 | FDA | None FDA-2020-D-1137 | REFERENCES LIST re Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Supporting & Related Material | Background Material | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T16:27:18Z | 0 | 0 | 090000648486b86f | |||
| FDA-2020-D-1137-0017 | FDA | None FDA-2020-D-1137 | Investigational COVID–19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance; Correction | Notice | Correction | 2020-10-07T04:00:00Z | 2020 | 10 | 2020-10-07T04:00:00Z | 2021-02-09T19:31:29Z | 2020-22142 | 0 | 0 | 09000064848e55db | |
| FDA-2020-D-1137-0019 | FDA | None FDA-2020-D-1137 | Emergency Use Authorization for Vaccines to Prevent COVID-19 - Guidance for Industry - October 2020 | Other | Guidance | 2020-10-06T04:00:00Z | 2020 | 10 | 2020-10-09T04:00:00Z | 2025-06-15T09:00:19Z | 1 | 0 | 09000064848efd71 | ||
| FDA-2020-D-1137-0018 | FDA | None FDA-2020-D-1137 | Investigational COVID-19 Convalescent Plasma; Guidance for Industry - FINAL | Other | Guidance | 2020-09-21T04:00:00Z | 2020 | 9 | 2020-10-08T04:00:00Z | 2024-11-06T23:39:54Z | 1 | 0 | 090000648486b9b9 | ||
| FDA-2020-D-1137-0011 | FDA | None FDA-2020-D-1137 | Guidance Documents Related to Coronavirus Disease 2019; Availability | Notice | Notice of Availability | 2020-08-03T04:00:00Z | 2020 | 8 | 2020-08-03T04:00:00Z | 2021-02-09T19:31:14Z | 2020-16852 | 0 | 0 | 09000064847ccc08 | |
| FDA-2020-D-1137-0008 | FDA | None FDA-2020-D-1137 | Guidance Documents Related to Coronavirus Disease 2019 (COVID–19); Availability | Notice | Notice of Availability | 2020-05-26T04:00:00Z | 2020 | 5 | 2020-05-26T04:00:00Z | 2021-02-09T19:30:57Z | 2020-11238 | 0 | 0 | 09000064846ac689 | |
| FDA-2020-D-1137-0007 | FDA | None FDA-2020-D-1137 | Guidance Documents Related to Coronavirus Disease 2019 (COVID–19); Availability | Notice | Notice of Availability | 2020-05-12T04:00:00Z | 2020 | 5 | 2020-05-12T04:00:00Z | 2021-02-09T19:30:39Z | 2020-10146 | 0 | 0 | 09000064845cd128 | |
| FDA-2020-D-1137-0002 | FDA | None FDA-2020-D-1137 | Alternative Procedures for Blood and Blood Components During the COVID-19 Public Health Emergency Guidance for Industry | Other | Guidance | 2020-04-03T04:00:00Z | 2020 | 4 | 2020-04-03T04:00:00Z | 2024-11-06T23:35:19Z | 1 | 0 | 090000648448551c | ||
| FDA-2020-D-1137-0001 | FDA | None FDA-2020-D-1137 | NOA - Process for Making Available Guidance Documents Related to Coronavirus Disease 2019 | Notice | Announcement | 2020-03-25T04:00:00Z | 2020 | 3 | 2020-03-25T04:00:00Z | 2020-09-18T22:29:39Z | 2020-06222 | 0 | 0 | 0900006484466342 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;